Headquartered in Belgium, GSK Biologicals has 13 manufacturing sites (including one in India) strategically positioned around the globe. In 2008,
GSK Biologicals distributed 1.1 billion doses of vaccines to 180 countries in both the developed and the developing world � an average of 3 million
doses a day.
In India GSK Biologicals has over 12 vaccines to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, rotavirus diarrhea, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis.